The Chinese Institute for Biomedical AI Science (CIBAS), at the Chinese Institutes for Medical Research, Beijing (CIMR), is pleased to host its inaugural international symposium, bringing together researchers and experts from computational life sciences, artificial intelligence, biomedical research, medicine, and pharmaceutical sciences.

Under the theme “AI in Biology and Medicine: From Computational Life Sciences to Biomedical Translation,” the symposium will explore how advances in AI, computational modeling, and high-performance computing are transforming our understanding of biological systems and accelerating biomedical innovation. Topics will span de novo protein design and protein engineering, physics-informed AI, computational physiology, behavioral analysis, AI-enabled medical imaging and diagnosis, cancer prognosis, protein–ligand interaction prediction, multiscale drug design, AI-aided drug discovery, and structure-informed RNA therapeutics.

By fostering interdisciplinary exchange across academia, medicine, and the pharmaceutical sector, the symposium aims to stimulate new collaborations, share emerging methodologies, and explore opportunities to translate computational and AI-driven discoveries into biomedical applications and therapeutic advances.

The event will feature invited talks by leading researchers from China and abroad, followed by a panel discussion on emerging opportunities and challenges at the intersection of AI, biology, medicine, and drug discovery.

首都医学科学创新中心生物医学人工智能研究所将举办首次国际学术研讨会，邀请来自计算生命科学、人工智能、生物医学、临床医学及药学等领域的专家学者，共同探讨人工智能驱动生命科学研究与医学创新的前沿进展和发展机遇。

本次研讨会以“人工智能在生物学与医学中的应用：从计算生命科学到生物医学转化”为主题，聚焦人工智能、计算建模与高性能计算在揭示生命系统复杂规律、推动生物医学研究及加速药物研发中的作用。会议议题涵盖从头蛋白质设计与蛋白质工程、物理原理与人工智能融合、计算生理学与行为分析，到人工智能辅助医学影像与诊断、肿瘤预后分析、蛋白质—小分子相互作用预测、多尺度药物设计、人工智能辅助药物发现，以及基于结构信息的RNA治疗策略等多个方向。

本次研讨会旨在促进人工智能、基础生命科学、临床医学与药物研发之间的交叉融合，加强不同学科及研究机构之间的交流与合作，探索计算方法与人工智能研究成果向生物医学应用和创新疗法转化的新路径。

会议将通过专题学术报告与圆桌讨论，交流相关领域的最新研究进展、关键挑战与未来发展方向，共同展望人工智能赋能生物学与医学的广阔前景。